249 related articles for article (PubMed ID: 29352139)
1. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
[TBL] [Abstract][Full Text] [Related]
2. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
Son J; Lyssiotis CA; Ying H; Wang X; Hua S; Ligorio M; Perera RM; Ferrone CR; Mullarky E; Shyh-Chang N; Kang Y; Fleming JB; Bardeesy N; Asara JM; Haigis MC; DePinho RA; Cantley LC; Kimmelman AC
Nature; 2013 Apr; 496(7443):101-5. PubMed ID: 23535601
[TBL] [Abstract][Full Text] [Related]
3. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.
Wang YP; Zhou W; Wang J; Huang X; Zuo Y; Wang TS; Gao X; Xu YY; Zou SW; Liu YB; Cheng JK; Lei QY
Mol Cell; 2016 Nov; 64(4):673-687. PubMed ID: 27840030
[TBL] [Abstract][Full Text] [Related]
4. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
Jeong SM; Hwang S; Park K; Yang S; Seong RH
Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
[TBL] [Abstract][Full Text] [Related]
5. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism.
Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y
Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862
[TBL] [Abstract][Full Text] [Related]
6. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
[TBL] [Abstract][Full Text] [Related]
8. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
[TBL] [Abstract][Full Text] [Related]
9. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
10. GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
Li Y; Li B; Xu Y; Qian L; Xu T; Meng G; Li H; Wang Y; Zhang L; Jiang X; Liu Q; Xie Y; Cheng C; Sun B; Yu D
Cancer Res; 2022 Sep; 82(18):3223-3235. PubMed ID: 35895805
[TBL] [Abstract][Full Text] [Related]
11. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
Kerk SA; Lin L; Myers AL; Sutton DJ; Andren A; Sajjakulnukit P; Zhang L; Zhang Y; Jiménez JA; Nelson BS; Chen B; Robinson A; Thurston G; Kemp SB; Steele NG; Hoffman MT; Wen HJ; Long D; Ackenhusen SE; Ramos J; Gao X; Nwosu ZC; Galban S; Halbrook CJ; Lombard DB; Piwnica-Worms DR; Ying H; Pasca di Magliano M; Crawford HC; Shah YM; Lyssiotis CA
Elife; 2022 Jul; 11():. PubMed ID: 35815941
[TBL] [Abstract][Full Text] [Related]
12. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
[TBL] [Abstract][Full Text] [Related]
13. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.
Recouvreux MV; Moldenhauer MR; Galenkamp KMO; Jung M; James B; Zhang Y; Lowy A; Bagchi A; Commisso C
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32510550
[TBL] [Abstract][Full Text] [Related]
14. GOT2 consider the tumor microenvironment.
Do BT; Vander Heiden MG
Trends Cancer; 2022 Nov; 8(11):884-886. PubMed ID: 36153305
[TBL] [Abstract][Full Text] [Related]
15. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
[TBL] [Abstract][Full Text] [Related]
16. Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism.
Bott AJ; Shen J; Tonelli C; Zhan L; Sivaram N; Jiang YP; Yu X; Bhatt V; Chiles E; Zhong H; Maimouni S; Dai W; Velasquez S; Pan JA; Muthalagu N; Morton J; Anthony TG; Feng H; Lamers WH; Murphy DJ; Guo JY; Jin J; Crawford HC; Zhang L; White E; Lin RZ; Su X; Tuveson DA; Zong WX
Cell Rep; 2019 Oct; 29(5):1287-1298.e6. PubMed ID: 31665640
[TBL] [Abstract][Full Text] [Related]
17. A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity.
Abrego J; Sanford-Crane H; Oon C; Xiao X; Betts CB; Sun D; Nagarajan S; Diaz L; Sandborg H; Bhattacharyya S; Xia Z; Coussens LM; Tontonoz P; Sherman MH
Cancer Discov; 2022 Oct; 12(10):2414-2433. PubMed ID: 35894778
[TBL] [Abstract][Full Text] [Related]
18. Autophagy is required for PDAC glutamine metabolism.
Seo JW; Choi J; Lee SY; Sung S; Yoo HJ; Kang MJ; Cheong H; Son J
Sci Rep; 2016 Nov; 6():37594. PubMed ID: 27892481
[TBL] [Abstract][Full Text] [Related]
19. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
20. Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Yang Y; Zheng M; Han F; Shang L; Li M; Gu X; Li H; Chen L
J Mol Med (Berl); 2022 Apr; 100(4):599-612. PubMed ID: 35212782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
